Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

2(33%)

Results Posted

25%(1 trials)

Phase Distribution

Ph not_applicable

17%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution1 total trials

N/ANon-phased studies

1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(4)

Detailed Status

Completed4

Recruiting2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

recruiting233%

completed467%

Recent Activity

2 active trials

Showing 5 of 6

recruiting

Clinical Trials (6)

Showing 6 of 6 trials

NCT05658497

Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)

Recruiting

NCT00493298

Tysabri Observational Program

Completed

NCT03399981

Tysabri Observational Cohort Study - Multiple Sclerosis (MS) Registries

Completed

NCT04565431

Examining Effects of Tysabri on Cognitive Fatigue Using fMRI

Recruiting

NCT01071512Not Applicable

Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis

Completed

NCT00937677

Effect of Tysabri in Patients With Relapsing-Remitting Multiple Sclerosis: A Follow-up Magnetization Transfer Imaging (MTI) Study

Completed

All 6 trials loaded

Drug Details

Intervention Type: BIOLOGICAL
Total Trials: 6